TASK 3: Responding to a Pharmaceutical query: REFERENCE SOURCES AVAILABLE FOR ENQUIRIES: Patient Information Leaflets: This leaflet is written by the manufacturing pharmaceutical companies and it important that all licensed products have leaflets available. This leaflet contains information about the product including information regarding side effects‚ medical conditions‚ allergies and interactions‚ doses and other information about the product. BNF and BNF for Children - British National
Premium Pharmacology Medicine Health care
currently has two reportable segments‚ the Pharmaceutical Segment and the Vaccines and Infectious Diseases Segment. Merck sells products through several channels including wholesalers‚ retailers‚ hospitals‚ clinics‚ government and managed health services providers. In the 1980’s the Merck was very successful in producing 10 major new drugs and had a very healthy pipeline. In later years‚ Merck has entered into joint ventures with many other pharmaceutical companies in order to expand its pipeline
Premium Generic drug Pharmaceutical industry Mergers and acquisitions
ORGANISATION OF PHARMACEUTICAL PRODUCERS OF INDIA Peninsula Corporate Park‚ Peninsula Chambers‚ Ground Floor‚ Ganpatrao Kadam Marg‚ Lower Parel‚ Mumbai 400 013. Telephone: 91 + 22 + 2491 8123‚ 2491 2486‚ 6662 7007 Fax: 91 + 22 + 2491 5168 Email: indiaoppi@vsnl.com OPPI PRE-BUDGET MEMORANDUM - 2013-2014 INDIRECT TAXES A. CUSTOMS DUTY Sr. No. 1. Issue Justification Customs duty exemption/ reduction to Life Saving It is imperative that critical life saving drugs be made available to
Premium Pharmacology Pharmaceutical drug Value added tax
atent-protection-ready/ Datamonitor Hoover ’s Company Records. Merck and Co.‚Inc. (2012). Retrieved from http://www.hoovers.com/company/Merck__Co_Inc/rrytji-1-1njhw5.html Hoover ’s Company Records CNN.com. (2011). Fortune 500 2011: Industry: Pharmaceuticals. Retrieved from http://money.cnn.com/magazines/fortune/fortune500/2011/industries/21/index.html Merck.com NYSE (2012). Retrieved from: http://www.advfn.com/p.php?pid=financials&symbol=NYSE%3AMRK Pfizer.com US Department of Treasury. (2012). Retrieved
Premium Pharmaceutical industry Pharmacology Generic drug
Case 1: Political‚ Legal‚ and Ethical Dilemmas in the Global Pharmaceutical Industry 1. What are the key issues and challenges faced by the global pharmaceutical industry? high cost of research and development 12-15 years and more than $800 million 1 in 10‚000 investigated and tested compounds is approved for patent use 3 out of 10 new‚ approved compounds are successful enough to recover their R&D costs high enough price to cover the cost of product development and cover the cost of products
Free Trademark Intellectual property Copyright
For me as a former worker in the medical field‚ who is coming from the other part of the world‚ the predilection for medicament over usage in the U.S. was always surprising. Therefore‚ I was expecting to see in this video issues about psycho-neurological side effects of overmedicated in somatically ill child. There were several memorable moments which impacted my mind. One of them was Jacob’s story. It was sad to see how the persistent labeling with hyperactivity by preschool teachers took
Premium Bipolar disorder Schizophrenia Antipsychotic
ELI LILLY IN INDIA RETHINKING THE JOINT VENTURE Kishore – 01 STRATEGY Abhay Abhishek Kunal – 05 Anil Kumar Jadli – 11 J.Harish – 25 Khushal Malik – 28 Sharad Singh – 49 PHARMACEUTICAL INDUSTRY – Global Trend • • • • Mainly concentrated in the United States‚ Europe‚ and Japan Developing a drug from discovery to launch took 10 to 12 years. Cost of development of drug is between $500-$800 million. Drugs were strictly controlled by government agencies: o Food and Drug Administration (FDA) – USA‚
Premium Generic drug Pharmaceutical industry Ranbaxy Laboratories
A project report on INTER COMPANY ANALYSIS Analysis of Pharmaceutical Industry in the Indian environment and comparative analysis among Ranbaxy Laboratories Ltd. and Cipla Ltd. Under the guidance of Prof P. Madhavan Visiting Professor‚ IIM Rohtak Undertaken by Ashwani Kumar Atif Aslam Dhiraj Rishiraj Sisodiya Shashi Singh pgp03.016 pgp03.017 pgp03.019 pgp03.054 pgp03.053 This project report is submitted as a partial requirement for the fulfilment of the Business Analysis and Valuation
Premium Financial ratios Financial ratio Generic drug
content Introduction Methods Results 1- Introduction to drug safety 2- The Drug Studies on Safety. 1- Pre-Approval studies 2- Post-Approval studies 3- Post marketing Studies Discussion References Introduction Pharmaceutical companies today like to produce many new drugs‚ but there are several potential risks associate with the production of any new medicine. In addition‚ there is numerous new side effects come from approved drugs. This paper aims to help understand
Premium Pharmacology Pharmaceutical industry Clinical research
of the Indian Pharmaceutical Industry. With the signing of the General Agreement of Trade and Tariff and the World Trade Organization Treaty‚ India agreed to recognize both product and process patents. This made patented drugs with a modified process. Due to this‚ India has developed tremendous competitive edge in the manufacturing bulk drugs and formulations. These abundant opportunities with their challenges are where I see myself making a contribution to the Indian Pharmaceutical Industry and in
Premium Pharmacy Pharmacology Pharmaceutical formulation